Leaderboard

En | De
Sie sind hier: Onkologie » Blut 03. Mai 2026
Suchen
medline.ch
Blut
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8371  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 167410  
   
Final results of nilotinib versus nilotinib combined with pegylated interferon alfa-2a as first-line therapy in chronic phase chronic myeloid leukaemia in France (PETALs): an open-label, multicentre, randomised phase 3 trial.
Lancet Haematol
Nicolini FE, Etienne G, Huguet F, Charbonnier A, Roth-Guépin G, Escoffre-Barbe M, Dubruille V, Johnson-Ansah H, Rousselot P, Legros L, Parry A, Roy L, Coiteux V, Lenain P, Ianotto JC, Doublet C, Orvain C, Simonet-Boissard M, Chrétien ML, Penot A, Meunier M, Amé S, Hermet E, Quittet P, Lapusan S, Schwiertz V, Cayuela JM, Mauté C, Réa D, Morisset S, Mahon FX, Dulucq S.
PMID: 42069411 [PubMed - indexed for MEDLINE]


Risks and benefits for patients with relapsed or refractory diffuse large B-cell lymphoma in early-phase clinical trials: a systematic review and meta-analysis.
Lancet Haematol
Spanjaart AM, Bakker M, de Vries R, Hutten BA, van Nieuwenhuijzen N, Minnema MC, Kuipers MT, Kersten MJ.
PMID: 42069410 [PubMed - indexed for MEDLINE]


Very early [(18)F]FDG-PET-guided targeted therapy in untreated advanced-stage classic Hodgkin lymphoma (EORTC-1537-COBRA): primary results of a single-arm, multicentre, phase 2 trial.
Lancet Haematol
Hutchings M, Diepstra A, Sureda Balari A, Carvalho S, Vranovsky A, Noordzij W, Loft A, Arens A, Teesink S, Visser L, Stevens W, Aleman BMP, Woei-A-Jin FJSH, Viguria M, Saevels K, Te Boome L, Tonino S, Meijnders P, Domingo Domènech E, Hasselbalch Riley C, Musekera L, Nuyens S, Mallien C, Sents W, Bührer E, Fortpied C, Plattel WJ.
PMID: 42069408 [PubMed - indexed for MEDLINE]


Two decades of phase 1 and 2 trials in relapsed or refractory diffuse large B-cell lymphoma.
Lancet Haematol
Baggio D, El-Galaly TC.
PMID: 42069405 [PubMed - in process]


Hematologic and molecular response to ropeginterferon alfa-2b in patients with polycythemia vera: a systematic review and meta-analysis.
Ann Hematol
Elgadi A, Wagealla M, Noorallah T, Esmail R, Almahi SS.
PMID: 42068356 [PubMed - indexed for MEDLINE]


Long-Term Follow-Up of Chidamide With Chemotherapy in Untreated Peripheral T-Cell Lymphoma: One Single Center Real-World Study in China.
Hematol Oncol
He J, Xia F, Yu L, Zou R, Zhu Q, Zhang X, Li J, Kong D, Wu D, Jin Z, Ping N, Qu C.
PMID: 42068310 [PubMed - indexed for MEDLINE]


Comparing the quality of dying for patients with hematological malignancy and solid tumors: A bereavement study in Japan.
Cancer
Ikeda S, Hiratsuka Y, Nakazawa Y, Miyashita M, Morita T, Okumura Y, Kizawa Y, Kawagoe S, Yamamoto H, Takeuchi E, Yamazaki R, Ogawa A.
PMID: 42068026 [PubMed - indexed for MEDLINE]


Serositis as possible manifestation in MDS/AML patients with complex karyotype and TP53 mutation: case series.
Ann Hematol
Gugole E, Tamellini E, Jance S, Serafin N, Antonini P, Colato C, Krampera M, Ferrarini I, Tanasi I.
PMID: 42067682 [PubMed - indexed for MEDLINE]


A multimodal explainable ai framework to assist in the differential diagnosis of head and neck reactive follicular hyperplasia and follicular lymphoma: an international multicentre study.
Virchows Arch
de Souza LL, Chen Z, de Cáceres CVBL, Rodrigues NG, Pontes HAR, Soares CD, Coracin FL, Kimura I, Siqueira SAC, Mariano FV, Kimura TC, Bonfitto JFL, de Freitas LLL, de Aquino SN, Hankinson P, Mahmood H, Walsh H, Torres Torres IA, Mosqueda-Taylor A, Aleixo PB, Martins MD, Menna-Barreto CL, Hagag A, Nakamura TCR, Dos Santos GC, Moraes MC, Lopes MA, Santos-Silva AR, Fonseca FP, Khurram SA, Vargas PA.
PMID: 42067664 [PubMed - as supplied by publisher]


CD135 (FLT3 receptor) expression as an indicator of prognosis in patients with de novo acute myeloid leukemia.
Ann Hematol
Nie J, Gao L, Shao Y, Yang L, Cao J, Xu J, Wang Y, Zhang Y, Cui T, Zhou S, Zhu W, Zhu M, Ma X, Wu D, Wu X.
PMID: 42067641 [PubMed - indexed for MEDLINE]


Preclinical and Clinical Evidence on the Efficacy and Cytotoxicity of Curcumin and Curcumin Derivatives in Chronic Myeloid Leukemia: A Systematic Review.
Phytochem Anal
Hosseini SM, Peymaninezhad F, Khademi F, Khiabani A, Khanahmad A, Farsinejad A, Bazi A.
PMID: 42067395 [PubMed - as supplied by publisher]


Impact of treatment for childhood acute lymphoblastic leukemia on later education, paid labor, and sickness- or activity compensation: A registry study from Sweden.
Cancer Epidemiol
Zhou O, Harila A, Hovén E, Lönnerblad M.
PMID: 42066742 [PubMed - as supplied by publisher]


How I Treat Plasma Cell Leukemia.
Blood
Al Hadidi S, van Rhee F, Anderson LD Jr.
PMID: 42066212 [PubMed - as supplied by publisher]


HTLV-1-Driven Clonal Evolution and Immune Escape in Adult T-Cell Leukaemia: From Viral Persistence to Therapeutic Failure.
Rev Med Virol
Mohammedsaleh ZM, Shater AF.
PMID: 42066066 [PubMed - indexed for MEDLINE]


A combined hematological and molecular study of Hodgkin lymphoma in Palestine: insights into subtype-specific prognosis and the role of Claudin-6/GATA-4.
Ann Hematol
Asees M, Amer J, Rezeq A, Salhab A, Abdalhaq T.
PMID: 42065778 [PubMed - indexed for MEDLINE]


Efficacy of fluoroquinolone prophylaxis during induction phase in children with acute lymphoblastic leukemia: a systematic review and meta-analysis.
Eur J Pediatr
Landivar MC, Hartmann Rost I, Carvalho Kilson A, Torres Campo MA, Santarosa Vieira AG.
PMID: 42065773 [PubMed - indexed for MEDLINE]


Prognostic value of nutritional and functional screening instruments for mortality in patients with hematologic malignancies.
Support Care Cancer
da Anunciação TA, Roriz AKC, Campos TRS, Varjão LM, de Souza CLS, da Silva Baqueiro Boulhosa RS, de Almeida Moreira P, Ramos LB, de Araújo MAS.
PMID: 42065753 [PubMed - indexed for MEDLINE]


Therapeutic Targets for Overcoming BCR::ABL1 Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia.
Oncol Res
Tsubaki M, Matsuo T, Komori R.
PMID: 42065050 [PubMed - indexed for MEDLINE]


Relapse in childhood B-cell precursor acute lymphoblastic leukemia: insights from transcriptomic signatures of diagnostic bone marrow.
Front Oncol
Oh L, Azanan MS, Ariffin H.
PMID: 42063739 [PubMed]


Consolidation cycles, measurable residual disease, and DNMT3A/ASXL1 mutations independently predict relapse-free survival in older adults with acute myeloid leukemia.
Front Oncol
Wang X, Liu X, Zang S, Liu J, Zhang J, Zhang X, Dong C, Zhang R.
PMID: 42063715 [PubMed]


   
   Artikel 1 - 20 / 167410    Seite 1 von 8371  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1